Cargando…
Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer
BACKGROUND: Multimodality therapy offers the best opportunity to improve pathological N2 non-small cell lung cancer (NSCLC) prognosis. This paper aimed to evaluate the long-term clinical outcomes and the prognostic factors of upfront surgery as first-line therapy in biopsy-proven clinical N2. METHOD...
Autores principales: | Bertolaccini, Luca, Prisciandaro, Elena, Guarize, Juliana, Girelli, Lara, Sedda, Giulia, Filippi, Niccolò, de Marinis, Filippo, Spaggiari, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366141/ https://www.ncbi.nlm.nih.gov/pubmed/35965495 http://dx.doi.org/10.3389/fonc.2022.933278 |
Ejemplares similares
-
Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
por: Bertolaccini, Luca, et al.
Publicado: (2021) -
A proposal for a postoperative protocol for the early diagnosis of bronchopleural fistula after lung resection surgery
por: Bertolaccini, Luca, et al.
Publicado: (2021) -
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
por: Guarize, Juliana, et al.
Publicado: (2021) -
In EBUS Signo Vinces: New Indications in Thoracic Oncology for Mediastinal Lymph Node Staging Using Endobronchial Ultrasound
por: Guarize, Juliana, et al.
Publicado: (2022) -
Preliminary Results of Robotic Lobectomy in Stage IIIA-N2 NSCLC after Induction Treatment: A Case Control Study
por: Casiraghi, Monica, et al.
Publicado: (2021)